Bellwether Report Is Closely Following MACR, CVTX, ONXX, and NAVR

Market Wire, April, 2005

The Bellwether Report is the leading online financial newsletter, focusing on small-cap emerging growth opportunities. We strive to introduce investors to truly undervalued opportunities in a time-friendly fashion, allowing for optimal entry points and profitable exit points. Today, we will be tracking the following companies to gauge the short-term sentiment of their market:

Macromedia Inc. (NASDAQ: MACR); CV Therapeutics Inc. (NASDAQ: CVTX); Onyx Pharmaceuticals Inc. (NASDAQ: ONXX); and Navarre Corp. (NASDAQ: NAVR). Investors interested in any of the above-mentioned companies are invited to sample the Bellwether Report for 30 days complimentary, and receive a full report on the company of your choosing.

Macromedia Inc. was up 10% following today's announcement that Adobe Systems will acquire Macromedia in an all-stock deal worth about 3.4 billion.

CV Therapeutics Inc. jumped to 9% following today's announcement that its experimental drug Ranexa reduced weekly angina frequency in a late stage trial.

Onyx Pharmaceuticals Inc. was trading up 7% following today's announcement that Bayer and Onyx unblind patients in an ongoing Sorafenib Phase III clinical trial in advanced renal cell carcinoma.

Finally, Navarre Corp. rose 9% following today's announcement that the company has a $165 million financing commitment from GE commercial finance.

For 30 days complimentary with the BWR service, feel free to visit www.bellwetherreport.com and sign up. No credit card needed!!

The Bellwether Report to date has not been compensated by any of the above-mentioned companies.

For More information contact: The Bellwether Report 1 877 702 1828 Support@bellwetherreport.com